OBJECTIVES: To identify predictors of complete renal response (CRR) and renal flares in SLE patients with active proliferative LN. METHODS: This was a retrospective cohort study over 36 months including patients with biopsy-proven proliferative LN (class III/IV), from two European tertiary centres. CRR and renal flare were defined as proteinuria 1 g/day after CRR attainment, respectively. Demographic, clinical and analytic parameters were evaluated as early predictors of renal outcome, using survival analysis. Candidate variables were tested as predictors for CRR at time 0, 3 and 6 months after starting induction treatment. Potential predictors for renal flare were evaluated at time of reaching CRR. Variables with P < 0.10 on univariate ana...
Background/Aim: Previous studies showed that renal hemodynamic parameters, especially the filtration...
BACKGROUND: Most patients with systemic lupus erythematosus (SLE) progress to lupus nephritis (LN) w...
Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis.BackgroundEven when tr...
OBJECTIVES: To describe renal outcomes of the lupus nephritis (LN) population of the University Medi...
Objectives: To identify predictors of overall lupus and lupus nephritis (LN) responses in patients w...
OBJECTIVES: To describe renal outcomes of the lupus nephritis (LN) population of the University Medi...
OBJECTIVES: To describe renal outcomes of the lupus nephritis (LN) population of the University Medi...
OBJECTIVES: To describe renal outcomes of the lupus nephritis (LN) population of the University Medi...
OBJECTIVES: To describe renal outcomes of the lupus nephritis (LN) population of the University Medi...
OBJECTIVE: End points currently used in lupus nephritis (LN) clinical trials lack uniformity and que...
Objective: There is a need to determine which response measures in lupus nephritis trials are most p...
Background: Lupus nephritis (LN) is a major determinant of mortality in systemic lupus erythematosus...
Background/Aim: Previous studies showed that renal hemodynamic parameters, especially the filtration...
Objective: Endpoints currently used in lupus nephritis (LN) clinical trials lack uniformity and ques...
Background/Aim: Previous studies showed that renal hemodynamic parameters, especially the filtration...
Background/Aim: Previous studies showed that renal hemodynamic parameters, especially the filtration...
BACKGROUND: Most patients with systemic lupus erythematosus (SLE) progress to lupus nephritis (LN) w...
Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis.BackgroundEven when tr...
OBJECTIVES: To describe renal outcomes of the lupus nephritis (LN) population of the University Medi...
Objectives: To identify predictors of overall lupus and lupus nephritis (LN) responses in patients w...
OBJECTIVES: To describe renal outcomes of the lupus nephritis (LN) population of the University Medi...
OBJECTIVES: To describe renal outcomes of the lupus nephritis (LN) population of the University Medi...
OBJECTIVES: To describe renal outcomes of the lupus nephritis (LN) population of the University Medi...
OBJECTIVES: To describe renal outcomes of the lupus nephritis (LN) population of the University Medi...
OBJECTIVE: End points currently used in lupus nephritis (LN) clinical trials lack uniformity and que...
Objective: There is a need to determine which response measures in lupus nephritis trials are most p...
Background: Lupus nephritis (LN) is a major determinant of mortality in systemic lupus erythematosus...
Background/Aim: Previous studies showed that renal hemodynamic parameters, especially the filtration...
Objective: Endpoints currently used in lupus nephritis (LN) clinical trials lack uniformity and ques...
Background/Aim: Previous studies showed that renal hemodynamic parameters, especially the filtration...
Background/Aim: Previous studies showed that renal hemodynamic parameters, especially the filtration...
BACKGROUND: Most patients with systemic lupus erythematosus (SLE) progress to lupus nephritis (LN) w...
Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis.BackgroundEven when tr...